EPIM
ONC

Evelyn Partners Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Evelyn Partners Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Hold
41
– – ﹤0.01% 352
2025
Q4 		$12.5K Hold
41
– – ﹤0.01% 350
2025
Q3 		$14K Hold
41
– – ﹤0.01% 340
2025
Q2 		$9.93K Hold
41
– – ﹤0.01% 359
2025
Q1 		$11.2K Hold
41
– – ﹤0.01% 350
2024
Q4 		$7.57K Buy
+41
New +$8.38K ﹤0.01% 372

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Evelyn Partners Investment Management's ONC Position: Q1 2026 in Review

Evelyn Partners Investment Management held its BeOne Medicines Ltd (ONC) position steady in Q1 2026 at 41 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #352.

Evelyn Partners Investment Management first reported a position in ONC in Q4 2024 and has held it in 6 quarters since. The position peaked at $14K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Evelyn Partners Investment Management held 41 shares of BeOne Medicines Ltd worth $12.2K as of Q1 2026.
  • Evelyn Partners Investment Management left its BeOne Medicines Ltd share count unchanged in Q1 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #352 holding.
  • Evelyn Partners Investment Management first reported a position in BeOne Medicines Ltd in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's BeOne Medicines Ltd position peaked at $14K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.